Search results
Results from the WOW.Com Content Network
The red blood cells are returned to the donor. The peripheral stem cell yield is boosted with daily subcutaneous injections of granulocyte-colony stimulating factor, serving to mobilize stem cells from the donor's bone marrow into the peripheral circulation. [39]
This is the side effect of conventional chemotherapy strategies that the stem-cell transplant attempts to reverse; a donor's healthy bone marrow reintroduces functional stem cells to replace the cells lost in the host's body during treatment.
The increase in white blood cell proliferation as a result of the Filgrastim ensures a better results from the donation. The course is usually given over a 4-day period prior to PBSC collection. [8] The most common side effects of Filgrastim are bone, joint, back, arm, leg, mouth, throat, and muscle pain. [9]
Akkina is one of the researchers involved with a phase 3 trial in organ transplant patients that uses stem cells taken from the organ donor in an attempt to wean the recipients off of these drugs ...
A savior sibling may be the solution for any disease treated by hematopoietic stem cell transplantation.It is effective against genetically detectable (mostly monogenic) diseases, e.g. Fanconi anemia, [4] Diamond–Blackfan anemia [5] and β-thalassemia, in the ailing sibling, since the savior sibling can be selected to not have inherited the disease.
The field of regenerative medicine, specifically stem cell therapy, also holds immense potential for tissue transplantation. The use of human pluripotent stem cells, specifically induced pluripotent stem cells, offers the cultivation of personalized tissues that minimize rejection risks. [34]
Donor lymphocyte infusion is the infusion in which lymphocytes from the original stem cell donor are infused, after the transplant, to augment an anti-tumor immune response or ensure that the donor stem cells remain engrafted. [1] [2] These donated white blood cells contain cells of the immune system that can recognize and destroy cancer cells.
When transplanting T-cell depleted stem cell transplant, GvHD can be partially prevented, but in the same time the GvL effect is also reduced, because T-cells play an important role in both of those effects. [8] The possibilities of GvL effect in the treatment of hematopoietic malignancies are limited by GvHD.